Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia

Diabetes Care

Volumn 26, Issue 4, 2003, Pages 1064-1068

  Greci, Laura S ^a,c   Kailasam, Mala ^a   Malkani, Samir ^a   Katz, David L ^b   Hulinsky, Ilja ^a   Ahmadi, Ramin ^a   Nawaz, Haq ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Griffin Prevention Research Center   (United States)

^c Eastern New Mexico Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOSE; HEMOGLOBIN A1C;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; PATIENT CARE; TREATMENT PLANNING;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CONNECTICUT; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, COMMUNITY; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; INPATIENTS; MIDDLE AGED; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY;

EID: 0042668662     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.4.1064     Document Type: Article

References (23)

1. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23:1278-1283, 2000
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey 1988-1994: Diabetes Care 21:518-524, 1988
3. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 15:815-819, 1992
4. Diabetes Control and Complications Trial (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
6. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive therapy in critically ill patients. N Engl J Med 345:1359-1367, 2001
7. McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 17:107-124, 2001
8. Madsen JK, Haunsoe S, Helquist S, Hommel E, Malthe I, Pedersen NT, Serigelov H, Ronnow-Jessen D, Telmer S, Parving HH: Prevalence of hyperglycemia and undiagnosed diabetes mellitus in patients with acute myocardial infarction. Acta Med Scand 220:329-332, 1986
9. Husband DJ, Alberti KG, Julian DG: "Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet 2:179-181, 1983
10. van Kooten F, Hoogerbrugge N, Naarding P, Koudstaal PJ: Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 24:1129-1132, 1993
11. O'Neill P, Davies L, Fullerton KJ, Bennett D: Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 22:842-847, 1991
12. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 24 (Suppl. 1):S5-S20, 2001
14. Modan M, Halkin H, Karasik A, Lusky A: Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol 119:431-444, 1984
15. Verrillo A, de Teresa A, Golia R, Nunziata V: The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance. Diabetologia 24:391-393, 1983
16. Hanson RL, Nelson RG, McCance DR, Beart JA, Charles MA, Pettitt DJ, Knowler WC: Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 153:2133-2140, 1993
17. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettin DJ, Bennett PH, Knowler WC: Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328, 1994
18. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE: Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23:187-191, 2000
19. American Diabetes Association: Tests of glycemia in diabetes (Position Statement). Diabetes Care 20 (Suppl. 1):S18-S20, 1997
20. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE: Unrecognized diabetes among hospitalized patients. Diabetes Care 21:246-249, 1998
21. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982, 2002
22. Krebs JD, Robinson GM, Smith RB, Toomath RJ: Follow up testing of hyperglycemia during hospital admission: combined use of fasting plasma glucose and HbA1c. N Z Med J 113:379-381, 2000
23. Engelgau MM, Narayan KM, Herman WH: Screening for type 2 diabetes. Diabetes Care 23:1563-1580, 2000